| scholarly article | Q13442814 |
| P50 | author | John S. Kuo | Q38328936 |
| Kyle I. Swanson | Q48506628 | ||
| Hong-En Chen | Q62849680 | ||
| Christopher J Pazoles | Q114390045 | ||
| P2093 | author name string | William Clarke | |
| Anne M Traynor | |||
| Perry J Pickhardt | |||
| Jamey P Weichert | |||
| Mohammed Farhoud | |||
| Paul A Clark | |||
| Lance T Hall | |||
| John M Floberg | |||
| Abram M Vaccaro | |||
| Benjamin Titz | |||
| Marc A Longino | |||
| Joseph Grudzinski | |||
| Anatoly N Pinchuk | |||
| Irawati K Kandela | |||
| P2860 | cites work | Exogenous ether lipids predominantly target mitochondria | Q27309030 |
| Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
| The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation | Q28270177 | ||
| Lipid rafts as a membrane-organizing principle | Q29615727 | ||
| EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer | Q29616360 | ||
| Radioimmunotherapy for non-Hodgkin's lymphoma: a review for radiation oncologists | Q33372605 | ||
| Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses | Q33924550 | ||
| Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy | Q34089324 | ||
| Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents | Q35088190 | ||
| Membrane organization and lipid rafts | Q35230032 | ||
| Recent trends in antibody-based oncologic imaging | Q35643425 | ||
| Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. | Q36062158 | ||
| Review of clinical radioimmunotherapy | Q36407480 | ||
| 131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review | Q36619849 | ||
| Differential expression of 2',3'-cyclic-nucleotide 3'-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival | Q36684457 | ||
| Inorganic Nanoparticles in Cancer Therapy | Q37812005 | ||
| Lipid rafts: signaling and sorting platforms of cells and their roles in cancer | Q37866316 | ||
| Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. | Q37938830 | ||
| Antibody-radionuclide conjugates for cancer therapy: historical considerations and new trends | Q37946340 | ||
| Virotherapy--cancer targeted pharmacology. | Q37971268 | ||
| Membrane mechanisms for signal transduction: the coupling of the meso-scale raft domains to membrane-skeleton-induced compartments and dynamic protein complexes | Q37981786 | ||
| The disturbed blood-brain barrier in human glioblastoma | Q37990264 | ||
| Anticancer mechanisms and clinical application of alkylphospholipids | Q38058582 | ||
| Rapid re-expression of CD133 protein in colorectal cancer cell lines in vitro and in vivo | Q39281785 | ||
| Isolation and characterization of cancer stem like cells in human glioblastoma cell lines | Q39881450 | ||
| A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells | Q40093876 | ||
| Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues | Q40298705 | ||
| A new method for the rapid and long term growth of human neural precursor cells | Q45855413 | ||
| Segregation of lipid raft markers including CD133 in polarized human hematopoietic stem and progenitor cells. | Q47255313 | ||
| The biocleavage of alkyl glyceryl ethers in Morris hepatomas and other transplantable neoplasms. | Q54568157 | ||
| Occurrence and nature of O-alkyl and O-alk-I-enyl moieties of glycerol in lipids of Morris transplanted hepatomas and normal rat liver | Q68597613 | ||
| Potential tumor or organ-imaging agents. 30. Radioiodinated phospholipid ethers | Q69703163 | ||
| Biological disposition and imaging of a radioiodinated alkylphosphocholine in two rodent models of breast cancer | Q71494030 | ||
| Synthesis and Biological Evaluation of Radioiodinated Phospholipid Ether Stereoisomers | Q71963269 | ||
| Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues | Q72335999 | ||
| Heteroaromatic thioether-boronic acid cross-coupling under neutral reaction conditions | Q77762771 | ||
| Simple, general, and efficient synthesis of meso-substituted borondipyrromethenes from a single platform | Q80976183 | ||
| Surface activation and targeting strategies of superparamagnetic iron oxide nanoparticles in cancer-oriented diagnosis and therapy | Q95822443 | ||
| P433 | issue | 240 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 240ra75 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Science Translational Medicine | Q1573955 |
| P1476 | title | Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy | |
| P478 | volume | 6 |
| Q64099822 | 90Y-NM600 targeted radionuclide therapy induces immunologic memory in syngeneic models of T-cell Non-Hodgkin’s Lymphoma |
| Q35942615 | A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application |
| Q33427321 | A Phase 1, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies |
| Q34523934 | A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety |
| Q39382994 | Administration of Non-Torsadogenic human Ether-à-go-go-Related Gene Inhibitors Is Associated with Better Survival for High hERG-Expressing Glioblastoma Patients |
| Q89967040 | Advanced Cancer Imaging Applied in the Comparative Setting |
| Q38841460 | Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model. |
| Q39091749 | Beyond the margins: real-time detection of cancer using targeted fluorophores |
| Q88328690 | CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer |
| Q52822419 | Design, synthesis and evaluation of alkylphosphocholine-gefitinib conjugates as multitarget anticancer agents. |
| Q64248450 | Development of a low-cost and portable smart fluorometer for detecting breast cancer cells |
| Q41638130 | Diapeutic cancer-targeting alkylphosphocholine analogs may advance management of brain malignancies. |
| Q57169517 | Enhanced Radiosensitivity in Solid Tumors using a Tumor-Selective Alkyl Phosphocholine Analog |
| Q27346925 | Fluorescent Cancer-Selective Alkylphosphocholine Analogs for Intraoperative Glioma Detection |
| Q39187880 | Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy. |
| Q37026387 | Fluorescent-Guided Surgical Resection of Glioma with Targeted Molecular Imaging Agents: A Literature Review |
| Q47209527 | High-Contrast Fluorescence Detection of Metastatic Breast Cancer Including Bone and Liver Micrometastases via Size-Controlled pH-Activatable Water-Soluble Probes |
| Q48368703 | Hypofractionated stereotactic radiosurgery for pituitary metastases |
| Q48208803 | Impact of PET and MRI threshold-based tumor volume segmentation on patient-specific targeted radionuclide therapy dosimetry using CLR1404. |
| Q91973876 | In Silico Docking of Alkylphosphocholine Analogs to Human Serum Albumin Predicts Partitioning and Pharmacokinetics |
| Q40084369 | Mitochondria and lipid raft-located FOF1-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine. |
| Q52685091 | Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. |
| Q37362790 | Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles |
| Q41180726 | PET/CT imaging of the diapeutic alkylphosphocholine analog 124I-CLR1404 in high and low-grade brain tumors |
| Q94156367 | POSTER PRESENTATIONS |
| Q94230866 | POSTER PRESENTATIONS |
| Q34294317 | Phospholipid ether analogs for the detection of colorectal tumors |
| Q92707295 | Preclinical Pharmacokinetics and Dosimetry Studies of 124I/131I-CLR1404 for Treatment of Pediatric Solid Tumors in Murine Xenograft Models |
| Q57796243 | Pretreatment CLR 124 Positron Emission Tomography Accurately Predicts CLR 131 Three-Dimensional Dosimetry in Triple-Negative Breast Cancer Patient |
| Q98164567 | Radiopharmaceutical therapy in cancer: clinical advances and challenges |
| Q47719762 | Radiotheranostics in Cancer Diagnosis and Management |
| Q34782793 | Recent developments in colorectal imaging |
| Q90332250 | Singular Interaction between an Antimetastatic Agent and the Lipid Bilayer: The Ohmline Case |
| Q38659292 | Targeted molecular radiotherapy of pediatric solid tumors using a radioiodinated alkyl-phospholipid ether analog |
| Q38858778 | Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems |
| Q41429183 | Tumor-selective anti-cancer effects of the synthetic alkyl phosphocholine analog CLR1404 in neuroblastoma |
| Q47161416 | Yeast display biopanning identifies human antibodies targeting glioblastoma stem-like cells. |
Search more.